Related Experiment Video
Updated: Sep 5, 2025

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with
Odayme Quesada1,2, Omeed Elboudwarej1, Michael D Nelson3
1Barbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Insights
Cardiomyocyte injury, indicated by ultra-high sensitivity cardiac troponin I (u-hscTnI), is linked to left ventricular (LV) remodeling and dysfunction in women with ischemia and no obstructive coronary artery disease (INOCA). Further research is needed to clarify the exact mechanisms.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Biomarker Research
Background:
- Women with ischemia and no obstructive coronary artery disease (INOCA) face a higher risk of heart failure with preserved ejection fraction (HFpEF).
- The underlying mechanisms connecting INOCA to HFpEF remain poorly understood, particularly regarding cardiomyocyte injury.
Purpose of the Study:
- To investigate the association between ultra-high sensitivity cardiac troponin I (u-hscTnI), a marker of cardiomyocyte injury, and myocardial perfusion, left ventricular (LV) structure, and function in women with INOCA.
Main Methods:
- Analysis of 327 women with INOCA from the WISE-CVD study.
- Utilized vasodilator stress cardiac magnetic resonance imaging (CMRI) and u-hscTnI measurements.
- Employed multivariable linear regression to assess relationships between u-hscTnI and LV mass index, and feature-tracking derived strain measures.
Main Results:
- Quantifiable u-hscTnI levels were found in 100% of participants.
- Elevated u-hscTnI concentrations were significantly associated with increased LV mass index and altered early diastolic strain rates (radial, circumferential, and longitudinal).
- No significant association was observed between u-hscTnI and myocardial perfusion reserve index (MPRI).
Conclusions:
- Cardiomyocyte injury, as indicated by u-hscTnI, may contribute to adverse LV remodeling and dysfunction in women with INOCA.
- These findings suggest a potential pathway linking INOCA to HFpEF through myocellular injury.
- Further research is required to elucidate the specific mechanisms driving cardiomyocyte injury in INOCA.
Aims:
Women are disproportionally impacted by ischemia and no obstructive coronary artery disease (INOCA), and such women are at increased risk of developing heart failure with preserved ejection fraction (HFpEF), however the mechanisms linking these conditions remain poorly understood. The aim of this study was to determine whether ultra-high sensitivity cardiac troponin I (u-hscTnI), an indicator of cardiomyocyte injury, is associated with abnormalities in myocardial perfusion and left ventricular (LV) structure and function in women with INOCA.
Methods:
327 women with INOCA enrolled in the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study underwent vasodilator stress cardiac magnetic resonance imaging (CMRI) and u-hscTnI measurements (Simoa HD-1 Analyzer, Quanterix Corporation). Multivariable linear regression was used to evaluate associations between u-hscTnI concentrations and myocardial perfusion (MPRI), LV mass index and feature-tracking derived strain measures of LV function.
Results:
u-hscTnI concentrations were quantifiable in 100% of the cohort and ranged from 0.004 to 79.6 pg/mL. In adjusted models, u-hscTnI was associated with LV mass index (+2.03; 95% CI 1.17, 2.89; p < 0.01) and early diastolic radial strain rate (SR) (+0.13; 95% CI 0.01, 0.25; p = 0.03), early diastolic circumferential SR (-0.04; 95% CI -0.08, 0.002; p = 0.06) and early diastolic longitudinal SR (-0.03; 95% CI -0.07, 0.002; p = 0.06). u-hscTnI was not associated with MPRI (p = 0.39) in adjusted models.
Conclusion:
Together, these findings support cardiomyocyte injury as a putative pathway towards adverse LV remodeling and dysfunction; however, further research is needed to define the specific mechanism(s) driving myocellular injury in INOCA.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina III: Clinical Manifestations and Assessment
Imaging Studies for Cardiovascular System V: CT